METTL5通过化学基因mRNA翻译调节使肝癌的免疫逃避成为可能
Shuang Li1, Xiao Zhao2, Tongtong Song1
1Department of Liver Surgery, Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 23, 2025
概括
METTL5是一种18SrRNA甲基转移酶,通过抑制CD8+T细胞促进肝癌. 它的抑制增强了抗瘤免疫力,并改善了肝脏内胆管癌 (ICC) 的免疫治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 肝脏的微环境极大地影响免疫监测和肝癌的进展.
- 18S rRNA m6A甲基转移酶METTL5在癌症中起作用,但其在肝脏免疫微环境中的功能尚不清楚.
研究的目的:
- 研究METTL5在调节肝脏免疫微环境和促进肝脏内胆管癌 (ICC) 进展中的作用.
- 探索METTL5作为ICC的潜在治疗点.
主要方法:
- 肝脏特定的Mettl5淘汰赛 (cKO) 鼠标模型.
- 单细胞RNA测序 (scRNA-seq) 和单细胞T细胞受体测序 (scTCR-seq).
- 免疫细胞的采用转移和治疗干预 (siRNA,PD-1阻断).
主要成果:
- Mettl5淘汰会增加CD8+T细胞的透,并抑制ICC的进展.
- 人类ICC中低METTL5表达与CD8+T细胞增加,巨细胞减少和更好的生存相关.
- METTL5降低了CXCL16的翻译,阻碍了CD8+T细胞的排斥.
- 结合METTL5向和PD-1阻断,消除了ICC瘤,并增强了免疫治疗反应.
结论:
- METTL5通过调解免疫逃避,主要通过抑制CD8+T细胞透来促进ICC.
- 向METTL5可以增强抗瘤免疫力,也是ICC的一种有前途的治疗策略.
- METTL5是ICC患者免疫治疗反应的潜在生物标志物.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


